In human breast cancer cells, S100a9 could promote autophagy by upregulating the Beclin-1 and promoting the formation of Atg12-Atg5 and lysosome activation, thereby inducing cell death [22, 39, 42, 43]. Here, ATG5 is linked to breast carcinoma.